In Brief this Week: Complete Genomics; Illumina; Danaher | GenomeWeb

NEW YORK (GenomeWeb News) – Complete Genomics disclosed in a filing with the US Securities and Exchange Commission this week that another lawsuit has been field against the firm by a "purported stockholder" alleging a breach in fiduciary duties in connection with the firm's proposed $117.6 million merger with BGI. It is the latest in a handful of suits filed against Complete Genomics, its board of directors, and executives seeking to block the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.